Search clinical trials for: Coronavirus disease-2019 (COVID-19)

Total 108103 results

Javier Eslava

Completed

Sociodemographic, Clinical, Quality of Life and Health Care Conditions in COVID-19 Survivors.

COVID-19 | Long COVID | Post-acute COVID-19 Syndrome | Long-COVID | Post-acute Sequelae of SARS-CoV-2 Infection

Colombia
Kaohsiung Kai-Suan Psychiatric Hospital

Not yet recruiting

The Impact and Coping Strategy of COVID-19 Among Taiwan Society and Medical and Nursing Institutes

The Psychological Impact of COVID-19
Janssen Vaccines & Prevention B.V.

Completed

A Study to Evaluate Different Dose Levels of Ad26.COV2.S in Healthy Adolescents From 12 to 17 Years Inclusive (HORIZON 2)

Coronavirus Disease-2019 (COVID-19) Prevention

Mexico, South Africa, Brazil, Argentina, India
Akesobio Australia Pty Ltd

Completed

A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects

Coronavirus Disease 2019 (COVID-19)

New Zealand
Ottawa Hospital Research Institute
ISBRG Corp

Recruiting

SpotLight-19 Research & Development Study

Screening

Canada
CSL Behring

Completed

Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19)

Coronavirus Disease 2019 (COVID-19)

United States
Guangzhou Institute of Respiratory Disease
Tongji Hospital; Guangzhou Eighth People's Hospital; Guangzhou Cellgenes Biotechnology...

Unknown

Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19)

Coronavirus Disease 2019 (COVID-19)

China
AstraZeneca

Terminated

Non-Interventional Enhanced Active Surveillance Study of Adults Vaccinated With AZD1222 (COVID-19)

Coronavirus Disease 2019 (COVID-19)

Germany
Tang-Du Hospital

Completed

Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia

Coronavirus Disease 2019 (COVID-19)

China
AbbVie

Completed

Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19)

CoronaVirus Disease-2019 (COVID-19)

United States, Hungary, Israel, Netherlands, Puerto Rico
University of Lahore

Completed

Theranostic Implication of Complementary Medicines Against Interleukin Receptors and Gp-130 Proteins

Corona Virus Disease 2019 (COVID-19)

Pakistan
Prothione, LLC

Completed

A Study to Evaluate the Efficacy and Safety of Prothione™ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19)

Coronavirus Disease 2019 (COVID-19)

Rwanda
Sinocelltech Ltd.

Completed

Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects

Coronavirus Disease 2019(COVID-19)

China
CSL Behring

Withdrawn

CSL324 in COVID-19

Coronavirus Disease 2019 (COVID-19)
Materia Medica Holding

Active, not recruiting

Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in Outpatients

Coronavirus Disease 2019 (COVID-19)

Russian Federation
AstraZeneca

Completed

A Study to Evaluate the Safety and Tolerability of AZD7442 in Chinese Adults

Coronavirus Disease 2019 (COVID-19)

China
CSL Behring

Terminated

Pharmacokinetics, Safety, and Tolerability of CSL760, an Intravenous Anti-SARS-CoV-2 Hyperimmune Globulin, in Healthy Adult Subjects

Coronavirus Disease 2019 (COVID-19)

Australia
Tychan Pte Ltd.

Completed

Safety of TY027, a Treatment for COVID-19, in Humans

Coronavirus Disease-2019 (COVID-19)

Singapore
I-Mab Biopharma Co. Ltd.

Completed

Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)

Coronavirus Disease 2019 COVID-19

United States
Huntington Memorial Hospital

Completed

Post COVID-19 Vaccination Analysis in Healthcare Worker Recipients

Covid19 | Vaccine Reaction

United States
Janssen Research & Development, LLC

Terminated

A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection (PREVENT-HD)

Coronavirus Disease 2019 (COVID-19)

United States
AstraZeneca

Completed

A Study to Evaluate the Safety and Tolerability of AZD7442 in Healthy Chinese Adults

Healthy Volunteer | Coronavirus Disease 2019 (COVID-19)

China
Yu Qin

Enrolling by invitation

Sequential Enhanced Safety Study of a Novel Coronavirus Messenger RNA (mRNA) Vaccine in Adults Aged 18 Years and Older.

Corona Virus Disease 2019(COVID-19)

China
National Institute of Allergy and Infectious Diseases...

Completed

Collection of Anti-SARS-CoV-2 Immune Plasma (NIAID)

Coronavirus Disease 2019 (COVID-19)

United States
Beijing 302 Hospital
Maternal and Child Health Hospital of Hubei Province; Huoshenshan Hospital; VCANBIO... and other collaborators

Completed

Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19)

Corona Virus Disease 2019(COVID-19)

China
University Hospital, Basel, Switzerland

Completed

Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19

Coronavirus Disease 2019 Infectious Disease (COVID-19 Infection)

Switzerland
AudibleHealth AI, Inc.
Sunrise Research Institute; Analytical Solutions Group, Inc.; Kelley Medical... and other collaborators

Completed

Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Clinical Validation

Coronavirus Disease 2019 | SARS-CoV-2 Infection | COVID-19 Pandemic | COVID-19 Virus Infection | Coronavirus Disease-19 | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease

United States
Kanuni Sultan Suleyman Training and Research Hospital

Completed

Mesenchymal Stem Cells Therapy in Patients With COVID-19 Pneumonia

Coronavirus Disease 2019 (COVID-19) Pneumonia

Turkey
Coordinación de Investigación en Salud, Mexico
Instituto Mexicano del Seguro Social

Unknown

Analysis of the Inflammatory Response and the Development of Humoral and Cellular Immunity in Patients With COVID-19

SARS-CoV-2

Mexico
Rigshospitalet, Denmark
Hvidovre University Hospital; Region Hovedstadens Apotek

Completed

COVID-19: SARS-CoV-2 Detection in Saliva, Oropharyngeal and Nasopharyngeal Specimens

Covid19 | SARS-CoV Infection | Coronavirus

Denmark
Rigshospitalet, Denmark

Recruiting

Should Palatine Tonsils be Included in the Oropharyngeal Swab for SARS-CoV-2 Molecular Testing?

Corona Virus Infection | SARS-CoV Infection | Coronavirus

Denmark
Scentech Medical Technologies Ltd

Completed

Early Detection of COVID-19 Using Breath Analysis (COVID-19)

Covid19

Israel
Leidos Life Sciences
United States Department of Defense

Withdrawn

Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)

COVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV-2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection
Leidos Life Sciences
United States Department of Defense

Terminated

Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients (Addendum 2)

COVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection

United States
Humanigen, Inc.

Active, not recruiting

Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19

Coronavirus Disease 2019 (COVID-19) Pneumonia

United States, Brazil
Fundacion Clinica Valle del Lili
Universidad Autonoma de Occidente

Completed

Convolutional Neural Network Model to Detect Coronavirus Disease 2019 (COVID-19) Pneumonia in Chest Radiographs (RedNeumon)

COVID-19 Pneumonia | COVID-19 (Coronavirus Disease 2019)

Colombia
Leidos Life Sciences
United States Department of Defense

Active, not recruiting

LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)

COVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV-2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection

United States
Universidad del Rosario
CES University; Fundación Universitaria de Ciencias de la Salud; Instituto Distrital...

Completed

Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study (CP-COVID-19)

Coronavirus Infection | Coronavirus

Colombia
Universidad del Rosario
CES University; Fundación Universitaria de Ciencias de la Salud; Instituto Distrital...

Completed

Convalescent Plasma for Patients With COVID-19: A Pilot Study (CP-COVID-19)

Coronavirus Infection | Coronavirus

Colombia
ModernaTX, Inc.

Recruiting

A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age

SARS-CoV-2

United States, Puerto Rico
Makerere University

Active, not recruiting

Hydroxychloroquine for Treatment of Non-Severe COVID-19 (HONEST)

Covid19

Uganda
Emory University

Withdrawn

Cetirizine and Famotidine for COVID-19

Covid19

United States
Beijing Ditan Hospital

Completed

A Clinical Study to Assess Preliminary Efficacy, Safety and Tolerability of HH-120 Nasal Spray in COVID-19 Patients

Coronavirus Disease 2019(COVID-19)

China
COVID-19 Prevention Network

Completed

SARS-CoV-2/COVID-19 Prevalence Study

COVID-19

United States, Puerto Rico
OncoImmune, Inc.

Completed

Efprezimod Alfa (CD24Fc, MK-7110) as a Non-antiviral Immunomodulator in COVID-19 Treatment (MK-7110-007) (SAC-COVID)

Coronavirus Disease 2019 (COVID-19)

United States
Cluster de Bioeconomia de Baja California, A.C
Bionag SAPI de CV; General Hospital Tijuana

Completed

Evaluation of Silver Nanoparticles for the Prevention of COVID-19 (COVID-19)

Coronavirus Disease 2019 (COVID-19)

Mexico
AstraZeneca

Terminated

A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19 (ENDURE)

Coronavirus Disease 2019 (COVID-19)

United States
Abu Dhabi Stem Cells Center

Completed

Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19 (SENTAD-COVID)

Coronavirus Disease 2019 (COVID-19)

United Arab Emirates
Weill Medical College of Cornell University

Terminated

COVID-19 (Coronavirus Disease-2019) Psychiatric Outcomes

Covid19 | Cognitive Impairment | Anxiety | Mood

United States
Unidad Temporal COVID-19 en Centro Citibanamex
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran; Instituto...

Completed

Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19 (ANTIOX-COVID)

Pneumonia, Viral | Covid19 | Oxidative Stress | ARDS

Mexico

Search clinical trials for: Coronavirus disease-2019 (COVID-19)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Philippines

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations